Nivolumab and ipilimumab in combination with radiotherapy in patients with high-risk locally advanced squamous cell carcinoma of the head and neck

Background The combination of nivolumab and ipilimumab has been approved for the treatment of multiple solid tumors. This was a phase I study investigating definitive radioimmunotherapy (RIT) with nivolumab and ipilimumab for the treatment of locally advanced (LA) squamous cell carcinoma of the head...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Madalina Tuluc, Ioannis A Vathiotis, Joseph Curry, Jennifer M Johnson, Ayesha Ali, Larry A Harshyne, Voichita Bar Ad, Rita Axelrod, Emily Lorber, David M Cognetti, Adam J Luginbuhl, Scott Keith, Mỹ G Mahoney, Athanassios Argiris
Format:	Artigo
Sprog:	Inglês
Udgivet:	BMJ Publishing Group 2023-08-01
Serier:	Journal for ImmunoTherapy of Cancer
Online adgang:	https://jitc.bmj.com/content/11/8/e007141.full
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!